ASCO GUIDELINES Bundle

Medication-Related Osteonecrosis of the Jaw

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475476

Contents of this Issue

Navigation

Page 5 of 13

6 Treatment Table 2. Proposed Terms to Characterize ONJ After Treatment Mucosal coverage Symptoms/ pain Signs of infection/ inflammation Radiographic Resolved Complete healing No pain None Trabecular pattern, formation lamina dura resorbed Improving Significant improvement (>50% of mucosal coverage) Significant improvement (>50% reduction of pain – VAS) Significant improvement (no signs of infection/ inflammation) Improved trabecular pattern Signs of sequestra Stable Mild improvement (<50% of mucosal coverage) Mild improvement (<50% reduction of pain – VAS) Mild improvement (mild signs of infection/ inflammation) No changes Progressive No improvement or worsening No improvement or worsening No improvement Lytic changes Decreasing trabeculation Increased size of radiographic lesion

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Medication-Related Osteonecrosis of the Jaw